Shyang-Rong, Shih
Dou-Liou City, Yun-Lin County, Taiwan
NCT Number: NCT00459459
The purpose of this study is to investigate the relationship between prognosis and fine needle aspiration cytology character of papillary thyroid cancer.
Looking for future studies?
Notify Me10 year–90 year
All sexes
Observational
Dou-Liou City, Yun-Lin County, Taiwan
Papillary thyroid carcinoma is the most common thyroid malignancy worldwide. The influence of clinicopathologic features on prognosis has been examined, but the relationship between cytologic features obtained by fine-needle aspiration (FNA) and prognosis has been minimally studied. We retrospectively studied the cytologic features with computerized morphometry in 83 patients with usual-type papillary thyroid cancer and followed them for more than 10 years except for one with metastasis at diagnosis. The cytologic features of FNA and recurrence of cancer were examined statistically.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Taiwan University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04139096
Disease Attributes, Disease Susceptibility
Villejuif, Val de Marne, France
View Trial DetailsNCT07575243
Endocrine Gland Neoplasms, Endocrine System Diseases
Asyut, Asyut Governorate, Egypt
View Trial DetailsNCT03573960
Endocrine Gland Neoplasms, Endocrine System Diseases
Bangalore, Karnataka, India
View Trial DetailsNCT05022667
Endocrine Gland Neoplasms, Endocrine System Diseases
Ann Arbor, Michigan, United States
View Trial Details